Form 4 for PBYI PUMA BIOTECHNOLOGY, INC.
Accepted 2026-01-08 00:00:00 ET · period of report 2026-01-06 · accession 0001437749-26-000924 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-01-08 | 2026-01-06+ | PBYI | AUERBACH ALAN H | Pres, CEO, Dir, 10% | S - Sale | $5.86 | -35.0K | 7.15M | -0.5% | -$204.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-06 | S | D | 16,938 | $5.84 | 7,163,963 | D | — | — | |
| 2 | Common | Common Stock | 2026-01-07 | S | D | 18,012 | $5.88 | 7,145,951 | D | — | — |